Hong Natarajan

Hong is the Vice Pres­i­dent and Head of Pro­gram Man­age­ment and Busi­ness Oper­a­tions at Metageno­mi. She has over 25 years of pro­gram and port­fo­lio man­age­ment expe­ri­ence in the phar­ma­ceu­ti­cal and biotech industry. 

Hong Natarajan's profile photo

VP of Program Management & Business Operations

Her last role was VP of Pro­gram Man­age­ment and Chief of Staff for the Pres­i­dent and COO at Roivant, where she played a cen­tral role in dri­ving R&D due dili­gence, asset acqui­si­tion and new-co stand-up. Pri­or to Roivant, Hong spent over 20 years at Kite, Amgen and Mer­ck col­lec­tive­ly, where she was the Glob­al Pro­gram Man­age­ment Lead for a num­ber of com­pa­ny flag­ship prod­ucts includ­ing Yescar­ta, Tecar­tus, Kypro­lis, Vectibix, Pro­lia and Lumakras in its ear­ly devel­op­ment, She also served as the PM TA lead at Amgen’s Oncol­o­gy Fran­chise Steer­ing Com­mit­tee and the CD19 B‑Cell Fran­chise at Kite. Hong is pas­sion­ate about find­ing cures to save and improve lives.

Hong received her Ph.D. in Ana­lyt­i­cal Chem­istry from Uni­ver­si­ty of Cincin­nati and an MBA from Stern School of Busi­ness at New York University.